UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Drug metabolism and disposition, ISSN 0090-9556, 09/2012, Volume 40, Issue 9, pp. 1744 - 1756
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Antihypertensive Agents - pharmacology | Tetrazoles - pharmacology | Species Specificity | Valsartan | Hypoglycemic Agents - metabolism | Benzoates - metabolism | Humans | Antihypertensive Agents - metabolism | Hepatocytes - metabolism | Angiotensin II Type 1 Receptor Blockers - pharmacology | Angiotensin II Type 1 Receptor Blockers - metabolism | Organic Anion Transporters - metabolism | Pyrimidines - metabolism | Quinolines - pharmacology | Tetrazoles - metabolism | Carbamates - metabolism | Dose-Response Relationship, Drug | Fluorobenzenes - pharmacology | Drug Interactions | Hydroxymethylglutaryl-CoA Reductase Inhibitors - metabolism | Biological Transport | Piperidines - pharmacology | Hepatocytes - drug effects | Carbamates - pharmacology | Pravastatin - pharmacology | Fluorobenzenes - metabolism | Piperidines - metabolism | Pravastatin - metabolism | Valine - analogs & derivatives | Rats | Rosuvastatin Calcium | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Hypoglycemic Agents - pharmacology | Quinolines - metabolism | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Valine - metabolism | Models, Biological | Benzimidazoles - metabolism | Sulfonamides - metabolism | Benzoates - pharmacology | Benzimidazoles - pharmacology | Kinetics | Valine - pharmacology | Organic Anion Transporters - drug effects | Index Medicus
Journal Article
Drug metabolism and disposition, ISSN 0090-9556, 08/2007, Volume 35, Issue 8, pp. 1308 - 1314
Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Organic Anion Transporters, Sodium-Independent - genetics | Fatty Acids, Monounsaturated - pharmacology | Cricetulus | Hypolipidemic Agents - metabolism | Hypoglycemic Agents - metabolism | Taurocholic Acid - metabolism | Humans | Hepatocytes - metabolism | Simvastatin - pharmacology | Organic Anion Transporters - metabolism | Chromans - metabolism | Hepatocytes - cytology | Indoles - metabolism | Organic Anion Transporters - genetics | Drug Interactions | Anticholesteremic Agents - metabolism | Chromans - pharmacology | Fatty Acids, Monounsaturated - metabolism | Organic Anion Transporters, Sodium-Independent - metabolism | Indoles - pharmacology | Biological Transport - drug effects | Thiazolidinediones - pharmacology | Hepatocytes - drug effects | Solute Carrier Organic Anion Transporter Family Member 1B3 | CHO Cells | Pravastatin - pharmacology | Recombinant Proteins - metabolism | Taurocholic Acid - pharmacology | Cell Line | Cricetinae | Pravastatin - metabolism | Simvastatin - metabolism | Gemfibrozil - pharmacokinetics | Gemfibrozil - pharmacology | Hypolipidemic Agents - pharmacology | Thiazolidinediones - metabolism | Hypoglycemic Agents - pharmacology | Animals | Estrone - analogs & derivatives | Estrone - metabolism | Protein Binding | Fatty Acids, Monounsaturated - pharmacokinetics | Indoles - pharmacokinetics | Kinetics | Solute Carrier Organic Anion Transporter Family Member 1b1 | Anticholesteremic Agents - pharmacology | Gemfibrozil - metabolism | Index Medicus
Journal Article
Journal of pharmacy and pharmacology, ISSN 0022-3573, 07/2016, Volume 68, Issue 7, pp. 883 - 889
Aristolochic acid I | Caco‐2 cell | monocarboxylic acid transporters | quercetin | breast cancer resistance protein | Monocarboxylic acid transporters | Breast cancer resistance protein | Caco-2 cell | Quercetin | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Caco-2 Cells | Pravastatin - pharmacology | Propionates - pharmacology | Cyclosporine - pharmacology | Benzoic Acid - pharmacology | Humans | Cells, Cultured | Intestinal Absorption - drug effects | Acetic Acid - pharmacology | Quinidine - pharmacology | Diketopiperazines - pharmacology | Heterocyclic Compounds, 4 or More Rings - pharmacology | Indomethacin - pharmacology | Quinolines - pharmacology | Aristolochic Acids - pharmacokinetics | Quercetin - pharmacology | Biological Transport - drug effects | Mitoxantrone - pharmacology | ATP-Binding Cassette Transporters - antagonists & inhibitors | Hydrogen-Ion Concentration | Benzoic acid | Organic acids | Monomolecular films | Acids | Ions | Index Medicus
Journal Article
Atherosclerosis, ISSN 0021-9150, 2010, Volume 215, Issue 1, pp. 1 - 8
Cardiovascular | Insulin resistance | Statins | Diabetes | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular system | Cardiology. Vascular system | Atherosclerosis (general aspects, experimental research) | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Vasodilator agents. Cerebral vasodilators | Blood and lymphatic vessels | Pravastatin - pharmacology | Adiponectin - biosynthesis | Humans | Diabetes Mellitus, Type 2 - prevention & control | Rosuvastatin Calcium | Clinical Trials as Topic | Pyrimidines - pharmacology | Simvastatin - pharmacology | Sulfonamides - pharmacology | Adiponectin - blood | Fluorobenzenes - pharmacology | Atorvastatin Calcium | Pyrroles - pharmacology | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Hydroxymethylglutaryl CoA Reductases - metabolism | Insulin Resistance - physiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Mice | Diabetes Mellitus, Type 2 - chemically induced | Homeostasis - drug effects | Heptanoic Acids - pharmacology | Glucose metabolism | RNA | Analysis | Simvastatin | Alternative medicine | Atherosclerosis | Glucose | Pravastatin | Dextrose | Antilipemic agents | Index Medicus
Journal Article
European journal of pharmacology, ISSN 0014-2999, 10/2015, Volume 764, pp. 283 - 291
Fluvastatin | Simvastatin | Atorvastatin | Rosuvastatin | Myocardial necrosis | Isoproterenol | Pravastatin | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Necrosis - drug therapy | Myocardial Infarction - chemically induced | Simvastatin - therapeutic use | Fatty Acids, Monounsaturated - pharmacology | Rosuvastatin Calcium - therapeutic use | Rats, Wistar | Atorvastatin Calcium - pharmacology | Glutathione - metabolism | Cholesterol - blood | Male | Simvastatin - pharmacology | Necrosis - pathology | Cardiotonic Agents - therapeutic use | Fatty Acids, Monounsaturated - therapeutic use | Myocardial Infarction - pathology | Myocardium - metabolism | Indoles - pharmacology | Pravastatin - therapeutic use | Atorvastatin Calcium - therapeutic use | Superoxide Dismutase - metabolism | Pravastatin - pharmacology | Blood Glucose - analysis | Rosuvastatin Calcium - pharmacology | Adenosine Triphosphatases - metabolism | Myocardium - pathology | Necrosis - metabolism | Cardiotonic Agents - pharmacology | Myocardial Infarction - metabolism | Necrosis - chemically induced | Catalase - metabolism | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Myocardial Infarction - drug therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Isoproterenol - pharmacology | Triglycerides - blood | Indoles - therapeutic use | Isoproterenol - therapeutic use | Antioxidants | Pharmacy | Drugstores | Glucose | Comparative analysis | Statins | Dextrose | Necrosis | Cardiotonic agents | Histochemistry | Cardiac glycosides | Index Medicus
Journal Article
Atherosclerosis, ISSN 0021-9150, 2016, Volume 254, pp. 215 - 227
Cardiovascular | Efficacy | Statin | Safety | Mortality | CHD | Blood-lipid | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Pravastatin - pharmacology | Fatty Acids, Monounsaturated - pharmacology | Lovastatin - pharmacology | Atorvastatin Calcium - pharmacology | Humans | Kidney Diseases - drug therapy | Treatment Outcome | Lovastatin - analogs & derivatives | Simvastatin - pharmacology | Quinolines - pharmacology | Randomized Controlled Trials as Topic | Coronary Disease - pathology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Lipids - blood | Muscles - drug effects | Bayes Theorem | Patient Safety | Coronary Disease - drug therapy | Indoles - pharmacology | Network Meta-Analysis | Anticholesteremic Agents - pharmacology | Epidemiology | Coronary heart disease | Analysis | Statins | Cardiovascular agents | Blood lipids | Index Medicus
Journal Article
Inflammation, ISSN 0360-3997, 10/2014, Volume 37, Issue 5, pp. 1355 - 1365
lung | Pathology | Medicine & Public Health | inflammation | statins | Rheumatology | Internal Medicine | Pharmacology/Toxicology | cigarette smoke | mice | oxidative stress | Immunology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Simvastatin - therapeutic use | Heptanoic Acids - therapeutic use | Oxidative Stress - physiology | Male | Simvastatin - pharmacology | Fluorobenzenes - pharmacology | Inflammation Mediators - metabolism | Anti-Inflammatory Agents - therapeutic use | Inhalation Exposure - adverse effects | Inflammation Mediators - antagonists & inhibitors | Lung - metabolism | Pyrroles - therapeutic use | Pravastatin - therapeutic use | Heptanoic Acids - pharmacology | Pravastatin - pharmacology | Lung - pathology | Anti-Inflammatory Agents - pharmacology | Mice, Inbred C57BL | Smoking - drug therapy | Rosuvastatin Calcium | Antioxidants - pharmacology | Pyrimidines - pharmacology | Sulfonamides - pharmacology | Atorvastatin Calcium | Smoking - metabolism | Antioxidants - therapeutic use | Pyrroles - pharmacology | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Lung - drug effects | Smoking - pathology | Mice | Oxidative Stress - drug effects | Fluorobenzenes - therapeutic use | Oxidative stress | Complications and side effects | Inflammation | Research | Cigarette smoke | Risk factors | Index Medicus
Journal Article